Prenatal screening for fetal defects has become a standard part of pregnancy medical care in the past couple of decades. Tests are typically conducted during the first half of pregnancy in order to detect a wide range of genetic and other disorders, and to give women the option of obtaining abortions if in case any defects are diagnosed. While some people believe this as a breakthrough in the prevention or eradications of diseases, it has significantly contributed to the improvement of society as a whole.
Due to the availability of many kinds of tests, parents are currently selecting the safer ones and also the technological developments have generally made the process of testing safe. These tests are also very effective and accurate, with several disorders being detected using single test, thus reducing the need for multiple visits and tests.
The global market for Prenatal testing and newborn screening was estimated to be $XX billion in 2014. The global market for Prenatal testing and new born screening is estimated to grow at a CAGR of XX% and is forecast to reach $XX billion by 2021. Prenatal testing market is forecast to have the highest growth of XX% during the forecast period 2016-2021. Health Care is the major end-user of prenatal testing and newborn screening. North America and Asia alone are estimated to occupy a share of more than XX% during 2016-2021.
North America is the leading market for prenatal testing and newborn screening with U.S leading the charge. Asia region is forecast to have highest growth in the next few years due to growing adoption of prenatal testing and newborn screening in industrial applications. Asia Prenatal testing and newborn screening market accounts to xx% of the global market. Asia is the fastest growing market followed by Americas.
1. Market Overview
2. Executive Summary
3. Prenatal Testing And Newborn Screening Market Landscape
3.1. Market Share Analysis
3.2. Comparative Analysis
3.2.1. Product Benchmarking
3.2.2. End User Profiling
3.2.3. Top 5 Financials Analysis4. Prenatal Testing And Newborn Screening Market-Forces
4.1. Market Drivers
4.2. Market Constraints & Challenges
4.2.1. Power Of Suppliers
4.2.2. Threats From New Entrants
4.2.3. Power Of Buyer
4.2.4. Threat From Substitute Product
4.2.5. Degree Of Competition5. Prenatal Testing And Newborn Screening Market-Strategic Analysis
5.1. Prenatal Testing And Newborn Screening Market - Value Chain Analysis
5.2. Pricing Analysis
5.3. Opportunity Analysis
5.4. Product Life Cycle
5.5. Suppliers And Distributors
5.6. Swot Analysis6. Prenatal Testing And Newborn Screening Market By Types
6.2. Screening Tests
6.3. Diagnosis Tests7. Prenatal Testing And Newborn Screening Market By Diagonising Technique
7.2. Non Invasive
7.2.2. Preimplementation Genetic Diagnosis
7.2.3. Fatel Cells In Maternal Circulation
7.2.4. Foetus-Free Fetal Dna
7.3.3. Fetal Blood Sampling
7.3.4. Embryoscopy &Fetoscopy8. Prenatal Testing And Newborn Screening Market By Screening Options
8.2. First Trimester
8.2.1. Nuclear Translucency(Nt)
8.2.2. Serum Screening
8.3. Second Trimester
8.3.1. Triple Screen
8.3.2. Quadraple Screen
8.3.3. Genetic Ssonogram
8.3.4. Extended Sonogram
8.4. Sequential Screening
8.5. Ultrasonography9. Prenatal Testing And Newborn Screening Market Bytechnology
9.1. Tandem Mass Spectrometry
9.3. Enzymes And Immuno Assays
9.4. Dna Based Assays
9.5. Pulse Oximetry Technology
9.6. Hearing Screen Technology10. Prenatal Testing And Newborn Screening Market By Instruments
10.1. Hearing Screen Instruments
10.2. Reagent And Assay Kits
10.3. Ultrasonography11. Prenatal Testing And Newborn Screening Market Market-By Geography
11.1.5. Rest Of America
11.2.5. Rest Of Europe
11.3.2. South Korea
11.3.5. Rest Of Apac
11.4. Rest Of The World (Row)
11.4.1. Middle East
11.4.2. Africa12. Prenatal Testing And Newborn Screening Market Market-Entropy
13. Company Profiles
13.1. Genetrack Biolabs Inc.
13.2. Verinata Health, Inc.
13.4. Hoffmann-La Roche Ltd.,
13.5. Bio-Rad Laboratories
13.6. Masimo Corporation
13.7. Perkinelmer Inc.
13.8. Genquest, Llc.
13.9. Identity Genetics, Inc.
13.10. Babycenter, L.L.C.*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
14.3. Research Methodology
14.4. Expert Insights